Levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack
RxNorm 2636817

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2636817 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack
AUI:12808607
View
SY
Levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack
AUI:12808996
View
GPCK
{2 (24 HR levomilnacipran 20 mg Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 mg Extended Release Oral Capsule) } Pack
AUI:12808602
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack
(Atom ID: 12808607)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
levomilnacipran 20 MG 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 MG 24HR Extended Release Oral Capsule (5) Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2636817
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12808607
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2636817
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Levomilnacipran 20 mg 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 mg 24HR Extended Release Oral Capsule (5) Pack
(Atom ID: 12808996)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
levomilnacipran 20 MG 24HR Extended Release Oral Capsule (2) / levomilnacipran 40 MG 24HR Extended Release Oral Capsule (5) Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2636817
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12808996
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2636817
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCKPrescribable

Generic Pack (GPCK):
{2 (24 HR levomilnacipran 20 mg Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 mg Extended Release Oral Capsule) } Pack
(Atom ID: 12808602)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule) / 5 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2636817
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12808602
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
2636817
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans